- Home
- ABUS vs CLB Comparison
ABUS vs CLB Comparison
Compare ABUS & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABUS
- CLB
- Stock Information
- Founded
- ABUS 2005
- CLB 1936
- Country
- ABUS United States
- CLB United States
- Employees
- ABUS N/A
- CLB N/A
- Industry
- ABUS Biotechnology: Pharmaceutical Preparations
- CLB
- Sector
- ABUS Health Care
- CLB
- Exchange
- ABUS Nasdaq
- CLB Nasdaq
- Market Cap
- ABUS 670.3M
- CLB 717.9M
- IPO Year
- ABUS N/A
- CLB 1995
- Fundamental
- Price
- ABUS $3.43
- CLB $12.41
- Analyst Decision
- ABUS Strong Buy
- CLB Hold
- Analyst Count
- ABUS 4
- CLB 4
- Target Price
- ABUS $5.50
- CLB $15.00
- AVG Volume (30 Days)
- ABUS 610.0K
- CLB 415.0K
- Earning Date
- ABUS 07-31-2025
- CLB 07-23-2025
- Dividend Yield
- ABUS N/A
- CLB 0.32%
- EPS Growth
- ABUS N/A
- CLB N/A
- EPS
- ABUS N/A
- CLB 0.59
- Revenue
- ABUS $6,403,000.00
- CLB $517,796,000.00
- Revenue This Year
- ABUS $3.35
- CLB N/A
- Revenue Next Year
- ABUS N/A
- CLB $2.92
- P/E Ratio
- ABUS N/A
- CLB $21.34
- Revenue Growth
- ABUS N/A
- CLB 1.32
- 52 Week Low
- ABUS $2.71
- CLB $10.15
- 52 Week High
- ABUS $4.73
- CLB $25.13
- Technical
- Relative Strength Index (RSI)
- ABUS 50.84
- CLB 57.69
- Support Level
- ABUS $3.46
- CLB $11.78
- Resistance Level
- ABUS $3.65
- CLB $13.05
- Average True Range (ATR)
- ABUS 0.12
- CLB 0.54
- MACD
- ABUS -0.00
- CLB 0.18
- Stochastic Oscillator
- ABUS 35.29
- CLB 74.80
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.